Details for 2019820938

Up to date per 02.04.2026

Actions

Title / Product Name

VERBESSERTE SYNTHESE EINES WICHTIGEN ZWISCHENPRODUKTES EINER KRAS-G12C-INHIBITORVERBINDUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019820938

EP Publication Number

3880670

E-Number

1574720

Language

PCT Number

US19061815

Publication Date

22.09.2021 A

07.06.2023 B1

Registration Date

07.06.2023

AT Publication Date

15.06.2023

Application Date

15.11.2019

Registration Number

Priorities

16.11.2018

201862768802 P

IPC

C07D 401/04 20060101AFI20200522BHEP

Maximum Duration of Protection

15.11.2039

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks, California 91320US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

PARSONS, Andrew ThomasOne Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, California 91320-1799US

COCHRAN, Brian McNeilOne Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, California 91320-1799US

POWAZINIK, IV, WilliamOne Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, California 91320-1799US

CAPORINI, Marc AnthonyOne Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, California 91320-1799US

Information about Fees